InvestorsHub Logo
Followers 0
Posts 365
Boards Moderated 0
Alias Born 10/03/2007

Re: None

Thursday, 09/10/2009 1:24:07 PM

Thursday, September 10, 2009 1:24:07 PM

Post# of 8313
Looked at JGBO's Rodman & Renshaw's presentation...

and listened to Elsa's presentation.

As usual Elsa's presentation are off to a rough start. Things that caught my attention are;
1. Shares outstanding 11.1 million
2. Shares outstanding fully diluted over 17 million
3. No mention of uplisting. Why?
4. All the numbers appear strong
5. Lalyang Pear cough syrup 6.1% sales growing fast

Long Vester, maybe you could help us out here, I and many others still don't understand, with Jiangbo's great revenues, why would Cao except a convertible debenture that would almost double the amount of shares for just $35 million? Seems rather foolish, however, I remember you saying that this would probably never happen. Can you explain?

Jiangbo was the last presentation of the day. Not very good placement as compared to all the rest of the companies.

I'm planning to spend some time to investigate the requirements for uplisting. I just wanted doublecheck to make sure were eligible and that there's not some hidden problem. They very easily could have mentioned the uplisting since they've already mentioned in past press releases. Just a statement saying "we still plan on uplisting soon" would not be out of the ordinary.

But I don't know anything. Go Jiangbo!

Bigplay 777

Bigplay777

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.